eastware pharmacy limited Company Information
Group Structure
View All
Industry
Dispensing chemist in specialised stores
Registered Address
2 burton house repton place, white lion road, amersham, buckinghamshire, HP7 9LP
Website
www.eastwarepharmacy.co.ukeastware pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of EASTWARE PHARMACY LIMITED at £512.8k based on a Turnover of £1.4m and 0.36x industry multiple (adjusted for size and gross margin).
eastware pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of EASTWARE PHARMACY LIMITED at £0 based on an EBITDA of £-102.6k and a 4.24x industry multiple (adjusted for size and gross margin).
eastware pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of EASTWARE PHARMACY LIMITED at £2.5m based on Net Assets of £1.2m and 2.09x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Eastware Pharmacy Limited Overview
Eastware Pharmacy Limited is a live company located in amersham, HP7 9LP with a Companies House number of 02904997. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in March 1994, it's largest shareholder is radiant medicare limited with a 100% stake. Eastware Pharmacy Limited is a mature, small sized company, Pomanda has estimated its turnover at £1.4m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Eastware Pharmacy Limited Health Check
Pomanda's financial health check has awarded Eastware Pharmacy Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 6 areas for improvement. Company Health Check FAQs


3 Strong

3 Regular

6 Weak

Size
annual sales of £1.4m, make it smaller than the average company (£12.3m)
- Eastware Pharmacy Limited
£12.3m - Industry AVG

Growth
3 year (CAGR) sales growth of -5%, show it is growing at a slower rate (7.6%)
- Eastware Pharmacy Limited
7.6% - Industry AVG

Production
with a gross margin of 32.4%, this company has a comparable cost of product (32.4%)
- Eastware Pharmacy Limited
32.4% - Industry AVG

Profitability
an operating margin of -9.4% make it less profitable than the average company (3.1%)
- Eastware Pharmacy Limited
3.1% - Industry AVG

Employees
with 13 employees, this is below the industry average (69)
13 - Eastware Pharmacy Limited
69 - Industry AVG

Pay Structure
on an average salary of £25.8k, the company has an equivalent pay structure (£25.8k)
- Eastware Pharmacy Limited
£25.8k - Industry AVG

Efficiency
resulting in sales per employee of £110.6k, this is less efficient (£144.8k)
- Eastware Pharmacy Limited
£144.8k - Industry AVG

Debtor Days
it gets paid by customers after 36 days, this is later than average (30 days)
- Eastware Pharmacy Limited
30 days - Industry AVG

Creditor Days
its suppliers are paid after 103 days, this is slower than average (64 days)
- Eastware Pharmacy Limited
64 days - Industry AVG

Stock Days
it holds stock equivalent to 31 days, this is in line with average (35 days)
- Eastware Pharmacy Limited
35 days - Industry AVG

Cash Balance
has cash to cover current liabilities for 60 weeks, this is more cash available to meet short term requirements (14 weeks)
60 weeks - Eastware Pharmacy Limited
14 weeks - Industry AVG

Debt Level
it has a ratio of liabilities to total assets of 24.8%, this is a lower level of debt than the average (59.1%)
24.8% - Eastware Pharmacy Limited
59.1% - Industry AVG
EASTWARE PHARMACY LIMITED financials

Eastware Pharmacy Limited's latest turnover from September 2023 is estimated at £1.4 million and the company has net assets of £1.2 million. According to their latest financial statements, Eastware Pharmacy Limited has 13 employees and maintains cash reserves of £444.9 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Sep 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | Apr 2014 | Apr 2013 | Apr 2012 | Apr 2011 | Apr 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 1,725,992 | 1,564,465 | ||||||||||||
Other Income Or Grants | ||||||||||||||
Cost Of Sales | 1,150,126 | 1,025,006 | ||||||||||||
Gross Profit | 575,866 | 539,459 | ||||||||||||
Admin Expenses | 401,719 | 388,453 | ||||||||||||
Operating Profit | 174,147 | 151,006 | ||||||||||||
Interest Payable | ||||||||||||||
Interest Receivable | 931 | 1,510 | ||||||||||||
Pre-Tax Profit | 181,225 | 152,516 | ||||||||||||
Tax | -41,178 | -30,420 | ||||||||||||
Profit After Tax | 140,047 | 122,096 | ||||||||||||
Dividends Paid | 25,000 | 25,000 | ||||||||||||
Retained Profit | 115,047 | 97,096 | ||||||||||||
Employee Costs | ||||||||||||||
Number Of Employees | 13 | 12 | 13 | 13 | 17 | 13 | 12 | |||||||
EBITDA* | 192,821 | 172,873 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Sep 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | Apr 2014 | Apr 2013 | Apr 2012 | Apr 2011 | Apr 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 59,988 | 116,098 | 83,777 | 5,931 | 7,658 | 7,956 | 7,110 | 9,440 | 10,629 | 10,563 | 11,059 | 10,082 | 8,683 | 6,799 |
Intangible Assets | 18,360 | 41,310 | 64,260 | 87,210 | 110,160 | |||||||||
Investments & Other | ||||||||||||||
Debtors (Due After 1 year) | ||||||||||||||
Total Fixed Assets | 59,988 | 116,098 | 83,777 | 5,931 | 7,658 | 7,956 | 7,110 | 9,440 | 10,629 | 28,923 | 52,369 | 74,342 | 95,893 | 116,959 |
Stock & work in progress | 83,111 | 86,505 | 81,062 | 77,169 | 86,153 | 81,692 | 89,436 | 93,595 | 89,163 | 92,789 | 109,151 | 117,883 | 111,635 | 91,504 |
Trade Debtors | 143,719 | 136,094 | 109,258 | 253,780 | 356,287 | 385,136 | 274,780 | 296,563 | 381,988 | 344,147 | 358,836 | 359,496 | 268,608 | 235,053 |
Group Debtors | ||||||||||||||
Misc Debtors | 879,531 | 186,262 | 243,324 | 4,137 | ||||||||||
Cash | 444,906 | 1,144,191 | 1,047,703 | 1,052,688 | 788,501 | 706,887 | 877,597 | 814,191 | 577,195 | 534,176 | 391,286 | 297,451 | 269,116 | 333,697 |
misc current assets | 4,903 | 4,651 | 4,716 | |||||||||||
total current assets | 1,551,267 | 1,553,052 | 1,481,347 | 1,383,637 | 1,235,078 | 1,178,618 | 1,246,464 | 1,209,065 | 1,048,346 | 971,112 | 859,273 | 774,830 | 649,359 | 660,254 |
total assets | 1,611,255 | 1,669,150 | 1,565,124 | 1,389,568 | 1,242,736 | 1,186,574 | 1,253,574 | 1,218,505 | 1,058,975 | 1,000,035 | 911,642 | 849,172 | 745,252 | 777,213 |
Bank overdraft | ||||||||||||||
Bank loan | 3,333 | |||||||||||||
Trade Creditors | 276,909 | 276,722 | 243,042 | 245,654 | 237,689 | 227,792 | 303,110 | 322,112 | 292,383 | 259,574 | 260,390 | 217,331 | 204,032 | 222,999 |
Group/Directors Accounts | ||||||||||||||
other short term finances | ||||||||||||||
hp & lease commitments | ||||||||||||||
other current liabilities | 108,399 | 59,305 | 64,713 | 48,768 | ||||||||||
total current liabilities | 385,308 | 336,027 | 311,088 | 294,422 | 237,689 | 227,792 | 303,110 | 322,112 | 292,383 | 259,574 | 260,390 | 217,331 | 204,032 | 222,999 |
loans | ||||||||||||||
hp & lease commitments | ||||||||||||||
Accruals and Deferred Income | 16,221 | 14,422 | 15,920 | 11,303 | ||||||||||
other liabilities | 46,667 | |||||||||||||
provisions | 13,640 | 26,625 | 15,918 | 791 | 1,350 | 1,350 | 412 | |||||||
total long term liabilities | 13,640 | 26,625 | 62,585 | 791 | 17,571 | 15,772 | 16,332 | 11,303 | ||||||
total liabilities | 398,948 | 362,652 | 373,673 | 295,213 | 255,260 | 243,564 | 319,442 | 333,415 | 292,383 | 259,574 | 260,390 | 217,331 | 204,032 | 222,999 |
net assets | 1,212,307 | 1,306,498 | 1,191,451 | 1,094,355 | 987,476 | 943,010 | 934,132 | 885,090 | 766,592 | 740,461 | 651,252 | 631,841 | 541,220 | 554,214 |
total shareholders funds | 1,212,307 | 1,306,498 | 1,191,451 | 1,094,355 | 987,476 | 943,010 | 934,132 | 885,090 | 766,592 | 740,461 | 651,252 | 631,841 | 541,220 | 554,214 |
Sep 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | Apr 2014 | Apr 2013 | Apr 2012 | Apr 2011 | Apr 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||||
Operating Profit | 174,147 | 151,006 | ||||||||||||
Depreciation | 33,258 | 18,674 | 21,867 | 2,682 | 3,493 | 2,854 | 2,330 | 3,189 | 3,889 | 3,946 | 4,600 | 4,049 | 4,101 | 4,446 |
Amortisation | 18,360 | 22,950 | 22,950 | 22,950 | 22,950 | 22,950 | ||||||||
Tax | -41,178 | -30,420 | ||||||||||||
Stock | -3,394 | 5,443 | 3,893 | -8,984 | 4,461 | -7,744 | -4,159 | 4,432 | -3,626 | -16,362 | -8,732 | 6,248 | 20,131 | 91,504 |
Debtors | 700,894 | -30,226 | 98,802 | -106,644 | -24,712 | 110,356 | -21,783 | -85,425 | 37,841 | -14,689 | -660 | 90,888 | 33,555 | 235,053 |
Creditors | 187 | 33,680 | -2,612 | 7,965 | 9,897 | -75,318 | -19,002 | 29,729 | 32,809 | -816 | 43,059 | 13,299 | -18,967 | 222,999 |
Accruals and Deferred Income | 49,094 | -5,408 | 15,945 | 32,547 | 1,799 | -1,498 | 4,617 | 11,303 | ||||||
Deferred Taxes & Provisions | -12,985 | 10,707 | 15,127 | -559 | 938 | 412 | ||||||||
Cash flow from operations | 215,405 | 68,218 | ||||||||||||
Investing Activities | ||||||||||||||
capital expenditure | ||||||||||||||
Change in Investments | ||||||||||||||
cash flow from investments | ||||||||||||||
Financing Activities | ||||||||||||||
Bank loans | -3,333 | 3,333 | ||||||||||||
Group/Directors Accounts | ||||||||||||||
Other Short Term Loans | ||||||||||||||
Long term loans | ||||||||||||||
Hire Purchase and Lease Commitments | ||||||||||||||
other long term liabilities | -46,667 | 46,667 | ||||||||||||
share issue | ||||||||||||||
interest | 931 | 1,510 | ||||||||||||
cash flow from financing | -49,069 | 51,510 | ||||||||||||
cash and cash equivalents | ||||||||||||||
cash | -699,285 | 96,488 | -4,985 | 264,187 | 81,614 | -170,710 | 63,406 | 236,996 | 43,019 | 142,890 | 93,835 | 28,335 | -64,581 | 333,697 |
overdraft | ||||||||||||||
change in cash | -699,285 | 96,488 | -4,985 | 264,187 | 81,614 | -170,710 | 63,406 | 236,996 | 43,019 | 142,890 | 93,835 | 28,335 | -64,581 | 333,697 |
eastware pharmacy limited Credit Report and Business Information
Eastware Pharmacy Limited Competitor Analysis

Perform a competitor analysis for eastware pharmacy limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in HP7 area or any other competitors across 12 key performance metrics.
eastware pharmacy limited Ownership
EASTWARE PHARMACY LIMITED group structure
Eastware Pharmacy Limited has no subsidiary companies.
eastware pharmacy limited directors
Eastware Pharmacy Limited currently has 1 director, Mr Neal Radia serving since Oct 2023.
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Neal Radia | England | 41 years | Oct 2023 | - | Director |
P&L
September 2023turnover
1.4m
-17%
operating profit
-135.9k
0%
gross margin
32.4%
-2.95%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
September 2023net assets
1.2m
-0.07%
total assets
1.6m
-0.03%
cash
444.9k
-0.61%
net assets
Total assets minus all liabilities
eastware pharmacy limited company details
company number
02904997
Type
Private limited with Share Capital
industry
47730 - Dispensing chemist in specialised stores
incorporation date
March 1994
age
31
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
September 2023
previous names
N/A
accountant
JACQUARDS
auditor
-
address
2 burton house repton place, white lion road, amersham, buckinghamshire, HP7 9LP
Bank
-
Legal Advisor
-
eastware pharmacy limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 8 charges/mortgages relating to eastware pharmacy limited. Currently there are 3 open charges and 5 have been satisfied in the past.
eastware pharmacy limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for EASTWARE PHARMACY LIMITED. This can take several minutes, an email will notify you when this has completed.
eastware pharmacy limited Companies House Filings - See Documents
date | description | view/download |
---|